Blood sugar management

Multi-strain probiotics improve glycaemic control of patients with diabetic nephropathy – 12-week RCT

08-Apr-2021 By Tingmin Koe

A combination of probiotic strains could improve glycaemic control when taken by patients with diabetic nephropathy, a 12-week RCT conducted in China has shown.

Probiotic’s obesity benefits partially translate from animals to humans: Study

29-Mar-2021 By Stephen Daniells

Dietary supplementation with the probiotic strain Bifidobacterium longum APC1472 may improve blood sugar levels in healthy overweight/obese adults, according to a new study from APC Microbiome Ireland.

Vitamin D deficiency, obesity and diabetes linked to higher rates of COVID-19 infection and mortality in Asia - Review

23-Mar-2021 By Guan Yu Lim

Vitamin D deficiency is linked to higher COVID-19 infection and mortality in Asian countries, according to the first review of its kind in the region.

Amazon’s dietary supplement specifications: “These requirements shouldn’t be terribly onerous”

10-Mar-2021 By Stephen Daniells

From the ISO accreditation issue to concerns around “by input”, the new Amazon specifications are sparking a lot of debate within the dietary supplements industry...

NAD supports claims being made by ‘medical probiotic’ manufacturer

03-Mar-2021 By Hank Schultz

Probiotics manufacturer Pendulum Therapeutics Inc. got some welcome news today when the National Advertising Division announced that it has found that the claims the company makes for dietary control of Type 2 diabetes are supported by scientific evidence.

Kawakawa innovation: NZ researchers to trial beverage for immunity, metabolic health gains

24-Feb-2021 By Tingmin Koe

New Zealand researchers are planning to conduct clinical trials on a kawakawa beverage with immune and metabolic health benefits, before refining the formulation and sell it in the export markets.

Curcumin-piperine combination may offer blood sugar benefits for diabetics: RCT

22-Feb-2021 By Stephen Daniells

A combination of extracts from turmeric and black pepper may improve fasting blood sugar levels and HbA1c (glycated hemoglobin) in people with type-2 diabetes, says a new study from Brazil.

Method details new way to extract algae-derived pigments for food supplement use

15-Feb-2021 By Will Chu

A way to extract pigments from microalgae for use in food supplements has been outlined by scientists, who think the method could overcome the difficulties in obtaining such pigments from natural sources.

Evolve BioSystems gets $55 million investment led by Cargill

10-Feb-2021 By Hank Schultz

Evolve BioSystems has announced $55 million in funding from Cargill and a private equity firm to bring its infant probiotic to market scale.

New legume flour improves blood glucose response to white bread

13-Jan-2021 By Flora Southey

Researchers in the UK have developed a new flour made from chickpeas they claim can lower the glycaemic response in people eating white bread.

Gut organisms’ metabolism effect a basis for T2D-specific probiotics, say researchers

07-Jan-2021 By Will Chu

Organisms living in the gut microbiome could become probiotic remedies for type 2 diabetes as researchers use a data-driven approach to identify species with beneficial effects on the host metabolism.

Berberine and probiotics combo successful in reducing blood sugar level in diabetic patients – China 12-week RCT

23-Nov-2020 By Tingmin Koe

The combined supplementation of the botanical berberine and probiotics has been found to help reduce blood sugar levels in diabetic patients, more so than taking each product alone, says a 12-week RCT conducted in China.

LBP products will benefit from ‘regulatory innovation,’ says European authority

18-Nov-2020 By Will Chu

There is an urgent need for clarification of concepts and constraints of the probiotics used in Live Biotherapeutic (LBP) products with success dependent on credible safety and efficacy demonstrations, says a European authority.

Study finds no benefits of dairy foods for blood sugar regulation

17-Nov-2020 By Jim Cornall

Results from a new trial published by a team led by researchers at Fred Hutchinson Cancer Research Center suggest lower dairy intake may be beneficial for people with metabolic syndrome.

MyBiotics granted €2m funding to develop personalised probiotics initiative

27-Oct-2020 By Will Chu

Microbiome therapeutics firm MyBiotics Pharma have received €2m ($2.3m) in funding by the European Union (EU) to develop technology capable of delivering personalised probiotics to tackle gut-related diseases.